Worth reading
46Recurring
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
27400
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise of Series 3 Stock Acquisition Rights issued through a third-party allotment using treasury shares (with exercise price adjustment and suspension request provisions)
発行・処分する株式数
New shares 0 shares (delivered during the month) / Treasury shares transferred 27,400 shares
発行済株式総数
Exercise ratio subject to exercise restrictions: 0.16% (27,400 shares delivered across all series / 17,674,400 listed shares as of the payment date for the issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Subject to exercise price adjustment. The exercise price during the target month was ¥1,198.0–¥1,235.8. The adjustment floor is not disclosed.
Number of Stock Acquisition Rights
Total issued: 9,000 rights (274 rights represented 3.04% of the total issued, calculated from the figures). Unexercised at the end of the preceding month: 8,906 rights; unexercised at the end of the target month: 8,632 rights
Procedures under the Corporate Code of Conduct
Describes compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments, etc.
Most recent equity financing
Timing 6 December 2023 / Type Issuance of Series 3 Stock Acquisition Rights (with exercise price adjustment and suspension request provisions) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise of Series 3 Stock Acquisition Rights issued through a third-party allotment using treasury shares (with exercise price adjustment and suspension request provisions) |
| Number of shares to be issued or disposed of | New shares 0 shares (delivered during the month) / Treasury shares transferred 27,400 shares |
| Dilution Rate | Exercise ratio subject to exercise restrictions: 0.16% (27,400 shares delivered across all series / 17,674,400 listed shares as of the payment date for the issuance) |
| Total number of issued shares | 17,674,400 shares (as of the end of the month preceding the target month) → Not disclosed |
| Exercise price | Subject to exercise price adjustment. The exercise price during the target month was ¥1,198.0–¥1,235.8. The adjustment floor is not disclosed. |
| Number of Stock Acquisition Rights | Total issued: 9,000 rights (274 rights represented 3.04% of the total issued, calculated from the figures). Unexercised at the end of the preceding month: 8,906 rights; unexercised at the end of the target month: 8,632 rights |
| Procedures under the Corporate Code of Conduct | Describes compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments, etc. |
| Most recent equity financing | Timing 6 December 2023 / Type Issuance of Series 3 Stock Acquisition Rights (with exercise price adjustment and suspension request provisions) / Amount Not disclosed |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of the Series 3 Stock Acquisition Rights for March 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.